Company Long-Term Loans and Borrowings: Trevena, Inc (TRVN)

Graphic logo of Trevena Inc. (TRVN)

The Trevena, Inc. (TRVN) price chart illustrates debt dynamics at the 0.00 level. The business attracts scientists through the development of non-opioid pain medications, offering specialists high bonuses and creative freedom. Risks are minimized by a portfolio of diverse neurobiological projects at various testing stages. Operational stability is ensured by the humanitarian status of medicine and the absence of geopolitical threats within the US legal framework.

Trevena Inc (TRVN) Company Long-Term Liabilities: for the period 07/04/2022 - 10/19/2024

Trevena, Inc (TRVN) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price trevena.com|TRVN - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Trevena|TRVN - Total Company Value
- book capitalization information:
Net Asset Value per Share Trevena|TRVN - Company Net Assets|Market Cap to Book Value Multiple trevena.com|TRVN - Aggregate Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Trevena, Inc.|TRVN - Long-Term Debt to Capital|Current Liabilities to Capital Trevena Inc|TRVN - Company Total Debt|Debt to Book Capitalization Ratio Trevena|TRVN - Company Long-Term Debts|Short-Term Debt Trevena|Immediate Liquidity Ratio trevena.com
- earnings and market multiples details:
TRVN - Net Profit
Fundamental company valuation:trevena.com (TRVN)
Brand item of Trevena

Long-term debt reflects the total obligations of Trevena, Inc. with maturities exceeding twelve months. By analyzing the trend of the issuer's long-term liabilities, an investor assesses the stability of the capital structure. Daily data recalculations eliminate time gaps between SEC quarterly reports. An increase in borrowings may heighten liquidity risk but accelerate capitalization. For TRVN, this is critical when implementing ESG standards and ensuring bioethics in the development of CNS drugs.

Who Trevena, Inc. competes with

Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|Company Long-Term Liabilities XENE|VKTX (vikingtherapeutics.com) - Amount of Long-Term Liabilities|Company Long-Term Debt Supernus (SUPN)|CPRX (Catalyst Pharma) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DNLI (Denali Therapeutics Inc)|Harmony Corp (HRMY) - Long-Term Debt|BHVN: Company Long-Term Liabilities|AMLX: Company Long-Term Debt|TRVI: Company Long-Term Debts|Long-Term Debt Praxis Precision Medicines Inc (PRAX)|Company Long-Term Debt Anavex Corp|Company Long-Term Indebtedness CBLL (CeriBell EEG)|Company Long-Term Debts PRTA|Company Long-Term Debts alector.com (ALEC)|Annexon - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings OMER|Neurogene Corp - Company Long-Term Debts|Long-Term Debt Volume AC Immune Inc ACIU|Voyager Therapeutics (VYGR) - Company Long-Term Debt|Company Long-Term Indebtedness NMRA|SCLX (Scilex) - Company Long-Term Debts|Company Long-Term Liabilities Tevogen Bio Holdings Inc. (TVGN)|Company Long-Term Liabilities ACOG (Alpha Cognition)|Long-Term Debt Volume cogrx.com|Inhibikase Therapeutics - Company Long-Term Liabilities|Amount of Long-Term Liabilities SAVA (cassavasciences.com)|ASRT - Company Long-Term Debt|Company Long-Term Loans and Borrowings COYA (Coya Therapeutics, Inc.)|VTGN (vistagen.com) - Company Long-Term Liabilities|OVID (Ovid Therapeutics) - Company Long-Term Debt|Company Long-Term Debt Acumen Pharmaceuticals|Company Long-Term Indebtedness CRVO (cervomed.com)|Company Long-Term Debt Alterity Therapeutics (ATHE)|clene.com - Company Long-Term Indebtedness|Company Long-Term Debts PEPG (PepGen)|jupiterneurosciences.com (JUNS) - Long-Term Debt|RLMD: Company Long-Term Liabilities|ANVS - Company Long-Term Debts|gracetx.com (GRCE) - Company Long-Term Debt|Firefly Neuroscience, Inc. - Company Long-Term Loans and Borrowings|Company Long-Term Debt ANEW Medical|Long-Term Debt NeuroSense Therapeutics, Ltd. NRSN|Company Long-Term Liabilities RVPH (Reviva Pharmaceuticals)|Amount of Long-Term Liabilities MTVA|Company Long-Term Debt NeurAxis NRXS|Company Long-Term Loans and Borrowings HSDT|Passage Bio Corp - Company Long-Term Debts|Long-Term Debt Neuphoria Therapeutics Inc.|NERV (Minerva Neurosciences) - Company Long-Term Liabilities|ATHA (athira.com) - Company Long-Term Debt|ADXN (Addex Therapeutics Ltd) - Company Long-Term Debts|Long-Term Debt Alzamend ALZN|Company Long-Term Debt Cyclerion Therapeutics (CYCN)|protagenic.com - Company Long-Term Indebtedness|Company Long-Term Debts KTTA (Pasithea Therapeutics Corp.)|Company Long-Term Debts Cortigent Inc CRGT|ATXI: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings BCLI (Brainstorm Cell Therapeutics Inc.)|CARA: Company Long-Term Debts|CHRO - Long-Term Debt Volume|Company Long-Term Debt Eliem Therapeutics, Inc.|Company Long-Term Indebtedness ITCI (Intra-Cellular)|Company Long-Term Debts LBPH|Company Long-Term Liabilities Marinus Pharmaceuticals Inc MRNS|NKGen - Company Long-Term Liabilities|Long-Term Debt Volume NeuroBo Pharma (NRBO)|SAGE: Company Long-Term Liabilities|synaptogen.com - Amount of Long-Term Liabilities|vigilneuro.com (VIGL) - Company Long-Term Debt|Anew Medical Inc. - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities CERE